Kobayashi Competitors

Delisted . USA . 
Stock . Kobayashi Pharmaceutical Co
KBYPFDelisted Stock  USD 32.49  0.00  0.00%   
Kobayashi Pharmaceutical competes with Waste Management, Logan Ridge, John Wiley, Skillful Craftsman, and Lincoln Educational; as well as few others. The company classifies itself under Consumer Defensive sector and is part of Household & Personal Products industry. Analyzing Kobayashi Pharmaceutical competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Kobayashi Pharmaceutical to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Kobayashi Pharmaceutical competition on your existing holdings.
  
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
32.4932.4932.49
Details
Intrinsic
Valuation
LowRealHigh
27.6227.6235.74
Details

Kobayashi Pharmaceutical Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Kobayashi Pharmaceutical and its competitors represents the degree of relationship between the price movements of corresponding pink sheets. A correlation of about +1.0 implies that the price of Kobayashi and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Kobayashi Pharmaceutical does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
WLYB
+ 0.79
WM
LINC
+ 0.66
LRFC
LRFC
+ 0.45
WM
WLYB
+ 0.37
LRFC
LINC
+ 0.35
WM
VSTA
+ 0.33
WM
  
High negative correlations   
VSTA
- 0.55
LINC
EDTK
- 0.41
WLYB
RMCO
- 0.28
EDTK
VSTA
- 0.26
LRFC
VSTA
- 0.2
EDTK
EDTK
- 0.19
WM

Risk-Adjusted Indicators

There is a big difference between Kobayashi Pink Sheet performing well and Kobayashi Pharmaceutical Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Kobayashi Pharmaceutical's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
All Fundamental Data

Kobayashi Pharmaceutical Competitive Analysis

The better you understand Kobayashi Pharmaceutical competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Kobayashi Pharmaceutical's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Kobayashi Pharmaceutical's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
KBYPF WM LRFC WLYB EDTK LINC RMCO ZNAE VSTA
 0.00 
 32.49 
Kobayashi
 0.33 
 211.71 
Waste
 0.62 
 23.92 
Logan
 1.51 
 43.70 
John
 3.51 
 1.10 
Skillful
 2.92 
 15.88 
Lincoln
 6.93 
 1.08 
Royalty
 0.00 
 0.0001 
Zane
 3.40 
 2.43 
Vasta
Market Volatility
(90 Days Market Risk)
Very steady
Very steady
Very steady
Very steady
Extremely Dangerous
Not too volatile
Extremely Dangerous
Very steady
Very risky
Market Performance
(90 Days Performance)
Very Weak
Weak
Very Weak
Very Weak
Insignificant
Good
Modest
Very Weak
Very Weak
Odds of Financial Distress
(Probability Of Bankruptcy)
Dangerous
Low
Quite High
About Average
Quite High
Very Small
Below Average
Low
Below Average
Current Valuation
(Equity Enterprise Value)
Over Valued
Fairly Valued
Over Valued
Fairly Valued
Over Valued
Under Valued
Over Valued
Over Valued
Fairly Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Buy
Strong Buy
Strong Sell
Not Available
Strong Buy
Not Available
Not Available
Hold
Trade Advice
(90 Days Macroaxis Advice)
Not Rated
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Current Ratio
3.92
0.85
3.46
0.64
3.43
1.92
N/A
N/A
1.5
Net Asset
252.55 B
32.82 B
197.09 M
2.73 B
36.32 M
345.25 M
13.61 M
N/A
7.4 B
Profit Margin
0.12
0.12
-0.16
-0.06
-2.36
0.0233
-2.46
N/A
-0.0398
EBITDA
32.49 B
5.59 B
3.78 M
52.26 M
(3.7 M)
42.76 M
(1.28 M)
N/A
459.99 M
Operating Margin
0.16
0.2
0.61
0.0759
-2.4
0.0264
-0.65
N/A
-0.24
Current Valuation
3.94 B
101.01 B
155.23 M
3.37 B
13.58 M
616.87 M
18.11 M
N/A
326.29 M
Price To Book
2.85
10.65
0.74
3.13
0.91
2.94
1.34
N/A
0.27
Retained Earnings
N/A
14.33 B
(99.26 M)
1.58 B
3.39 M
69.28 M
1.35 M
N/A
(331.56 M)
Current Asset
N/A
2.35 B
N/A
N/A
N/A
105.09 M
N/A
N/A
1.89 M
Five Year Return
N/A
1.79
N/A
2.78
N/A
N/A
N/A
N/A
N/A
Beta
0.27
0.75
1.28
0.85
-0.28
1.41
-0.24
1.69
0.12
Number Of Employees
3.45 K
48 K
N/A
6.4 K
71
1.8 K
N/A
1
1.43 K
Shares Outstanding
76.01 M
401.37 M
2.67 M
8.97 M
15.93 M
31.48 M
14.93 M
N/A
15.74 M
Cash Flow From Operations
22.42 B
4.72 B
16.83 M
207.64 M
(2.66 M)
25.56 M
(1.91 M)
N/A
218.85 M
Annual Yield
0.013
0.0142
0.056
0.0306
N/A
N/A
N/A
N/A
N/A
Total Debt
596 M
16.23 B
101.52 M
887.28 M
13.25 M
116.79 M
2.4 M
N/A
1.15 B
Return On Equity
0.0968
0.35
-0.0365
-0.13
-0.19
0.0602
-0.17
N/A
-0.0138
Z Score
5.4
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return On Asset
0.0633
0.0795
0.0381
0.051
-0.0315
0.0197
-0.077
N/A
0.0145
Book Value Per Share
2652.56
19.88
32.31
13.59
1.39
5.4
0.67
N/A
54.67
Number Of Shares Shorted
N/A
3.36 M
5.41 K
152
10.39 K
181.95 K
15.63 K
N/A
13.4 K
Current Liabilities
N/A
2.51 B
N/A
N/A
N/A
71.45 M
N/A
N/A
2.1 M
Total Asset
252.55 B
32.82 B
197.09 M
2.73 B
36.32 M
345.25 M
13.61 M
N/A
7.4 B
Debt To Equity
0.003
2.01
1.0
1.0
0.3
0.72
N/A
N/A
0.24
Last Dividend Paid
84.0
2.95
1.28
N/A
N/A
N/A
N/A
N/A
N/A
Short Ratio
N/A
1.97
0.8
0.9
0.9
1.23
4.34
N/A
0.06
Target Price
N/A
231.4
27.0
N/A
N/A
20.0
N/A
N/A
2.58
Shares Owned By Institutions
21.77
83.78
26.81
3.49
4.89
66.68
1.25
N/A
65.75
Market Capitalization
5.37 B
84.97 B
63.78 M
2.38 B
17.52 M
499.89 M
16.13 M
N/A
194.82 M
Price To Earning
34.29
30.57
30.63
22.41
N/A
4.61
N/A
N/A
N/A
Price To Earnings To Growth
N/A
2.26
-1.44
2.47
N/A
1.53
N/A
N/A
39.96
Price To Sales
0.0289
3.97
3.2
1.3
8.77
1.18
25.03
N/A
0.13
Net Income
19.71 B
2.28 B
(2.48 M)
(200.32 M)
(4.72 M)
26 M
(2.07 M)
N/A
(119.7 M)
Earnings Per Share
1.94
6.54
-1.22
-0.92
-0.48
0.32
-0.09
N/A
-0.13
Shares Owned By Insiders
34.5
0.21
10.2
91.62
51.81
7.62
50.42
N/A
51.09
Revenue
155.25 B
20.43 B
3.78 M
1.87 B
2 M
378.07 M
361.62 K
N/A
1.49 B
Working Capital
N/A
(422 M)
N/A
(419.24 M)
17.3 M
61.25 M
(1.08 M)
N/A
9.53 M
Cash And Equivalents
116.15 B
351 M
29.49 M
105.8 M
23.83 M
66.98 M
N/A
N/A
565.53 M
Cash Per Share
N/A
0.33
10.88
1.9
1.6
2.5
N/A
N/A
6.86
Gross Profit
88.77 B
8.41 B
19.94 M
1.32 B
169.39 K
245.55 M
578.63 K
N/A
981.89 M
Day Typical Price
32.49
211.91
23.94
43.7
1.12
15.82
1.07
1.0E-4
2.4
Accumulation Distribution
N/A
0.0113
0.0252
N/A
0.0435
0.0275
0.0727
N/A
0.0531
Market Facilitation Index
N/A
2.41
0.61
N/A
0.05
0.44
0.08
N/A
0.13
Daily Balance Of Power
0.0
0.2905
(0.25)
9.2 T
(0.80)
1.022727
0.875
0.0
0.6154
Period Momentum Indicator
N/A
0.7
(0.15)
0.65
(0.04)
0.45
0.07
N/A
0.08
Rate Of Daily Change
1.0
1.0
0.99
1.02
0.96
1.03
1.07
1.0
1.03
Day Median Price
32.49
212.02
23.95
43.7
1.13
15.79
1.06
1.0E-4
2.38
Price Action Indicator
N/A
0.045
(0.10)
0.33
(0.04)
0.32
0.055
N/A
0.085
Coefficient Of Variation
(812.40)
(51,305)
13652.52
(2,921)
1901.09
674.9
1542.42
N/A
(13,285)
Mean Deviation
0.4937
0.7311
0.834
1.05
3.06
2.0
3.64
N/A
2.49
Jensen Alpha
(0.26)
(0.02)
5.0E-4
(0.07)
0.188
0.3748
0.2898
N/A
(0.05)
Total Risk Alpha
(0.31)
(0.04)
(0.03)
(0.11)
0.1004
0.3276
0.1781
N/A
(0.12)
Sortino Ratio
N/A
N/A
(0.02)
N/A
0.045
0.1518
0.0653
N/A
N/A
Downside Variance
N/A
N/A
1.73
N/A
14.31
5.99
16.57
N/A
N/A
Standard Deviation
2.04
1.07
1.15
1.72
3.8
2.71
4.56
N/A
3.61
Kurtosis
66.0
7.58
1.36
4.84
(0.60)
1.73
(0.17)
N/A
3.21
Potential Upside
N/A
1.45
1.93
2.14
7.22
4.4
8.49
N/A
4.39
Treynor Ratio
12.9
(0.03)
0.0148
0.9009
1.91
0.4658
(1.31)
N/A
(0.05)
Maximum Drawdown
16.54
7.34
6.46
12.46
14.88
14.72
21.04
N/A
21.46
Variance
4.15
1.15
1.32
2.94
14.46
7.34
20.78
N/A
13.05
Market Risk Adjusted Performance
12.91
(0.02)
0.0248
0.9109
1.92
0.4758
(1.30)
N/A
(0.04)
Risk Adjusted Performance
(0.1)
6.0E-4
0.0088
(0.02)
0.0518
0.1308
0.0624
N/A
0.0014
Skewness
(8.12)
1.52
(0.33)
(0.87)
0.3196
0.5955
0.4102
N/A
0.6659
Semi Deviation
N/A
N/A
1.18
N/A
3.24
2.05
3.68
N/A
N/A
Information Ratio
(0.14)
(0.03)
(0.02)
(0.05)
0.0448
0.1372
0.0583
N/A
(0.02)
Value At Risk
N/A
(1.72)
(1.81)
(2.95)
(5.61)
(3.85)
(6.42)
N/A
(5.56)
Expected Short fall
N/A
N/A
(0.84)
N/A
(3.69)
(2.20)
(4.59)
N/A
N/A
Downside Deviation
N/A
N/A
1.32
N/A
3.78
2.45
4.07
N/A
N/A
Semi Variance
N/A
N/A
1.4
N/A
10.53
4.22
13.58
N/A
N/A

Kobayashi Pharmaceutical Competition Performance Charts

Five steps to successful analysis of Kobayashi Pharmaceutical Competition

Kobayashi Pharmaceutical's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Kobayashi Pharmaceutical in relation to its competition. Kobayashi Pharmaceutical's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Kobayashi Pharmaceutical in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Kobayashi Pharmaceutical's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Kobayashi Pharmaceutical, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Kobayashi Pharmaceutical position

In addition to having Kobayashi Pharmaceutical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Utilities ETFs Thematic Idea Now

Utilities ETFs
Utilities ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Utilities ETFs theme has 13 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Utilities ETFs Theme or any other thematic opportunities.
View All  Next Launch
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Other Consideration for investing in Kobayashi Pink Sheet

If you are still planning to invest in Kobayashi Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Kobayashi Pharmaceutical's history and understand the potential risks before investing.
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Fundamental Analysis
View fundamental data based on most recent published financial statements
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY